-
Original Article11-28-2005
Prevalence of overweight and obesity among climacteric women
Revista Brasileira de Ginecologia e Obstetrícia. 2005;27(8):479-484
Abstract
Original ArticlePrevalence of overweight and obesity among climacteric women
Revista Brasileira de Ginecologia e Obstetrícia. 2005;27(8):479-484
DOI 10.1590/S0100-72032005000800008
Views109See morePURPOSE: to evaluate the prevalence of overweight and obesity among climacteric women. METHODS: this cross-sectional study included 611 women aged between 45 and 60 years attended at a climacteric clinic from January to June 2003. The prevalence of overweight and obesity was evaluated through the body mass index (BMI). Overweight or obesity was considered when there was a BMI equal or higher than 25 kg/m². Sociodemographic and reproductive variables as well as life style were also evaluated. The chi2 test followed by logistic regression was performed for statistical analysis. RESULTS: the average age of the studied women was 51.4 (±4.4) years, whereas 52.9% of them were postmenopausal. About 63.7% of them had a BMI equal or higher than 25 kg/m². The prevalence of overweight and obesity was 33.6 and 30.1%, respectively. The prevalence of overweight and obesity was higher among older women (OR=1.2; 95%IC: 1.1-1.4) or non hormonal therapy users (OR=1.8; 95%IC: 1.2-2.8). The opposite was observed among the women without a professional occupation (OR=0.6; 95%IC: 0.5-0.9) or a steady partner (OR=0.7; 95%IC: 0,4-0,9). CONCLUSIONS: in this study, the prevalence of overweight and obesity was influenced by age, but not by the menopausal status. The association between the marital status and occupation and the BMI strengthens the hypothesis that the health of the climacteric women may be influenced by biological factors as well as by psychosocial factors and life style. The lowest prevalence of overweight and obesity among the users of hormonal therapy may be explained by possible restrictions in relation to its prescription for women with previous overweight or obesity. Further studies are necessary to get more conclusive results, in particular with longitudinal studies.
PlumX Metrics- Citations
- Citation Indexes: 7
- Usage
- Full Text Views: 28809
- Abstract Views: 2322
- Captures
- Readers: 34
-
Original Article10-13-2000
Variations in the Body Mass Index in Users of Hormone Replacement Therapy
Revista Brasileira de Ginecologia e Obstetrícia. 2000;22(4):229-233
Abstract
Original ArticleVariations in the Body Mass Index in Users of Hormone Replacement Therapy
Revista Brasileira de Ginecologia e Obstetrícia. 2000;22(4):229-233
DOI 10.1590/S0100-72032000000400007
Views118See morePurpose: to evaluate the effects of hormone replacement therapy on the body mass index of postmenopausal women. Methods: for this purpose, 166 users and 136 non-users of hormone replacement were evaluated retrospectively during a period of three years. All women were assisted at the Menopause Outpatient Clinic of CAISM - UNICAMP, where the variations in this parameter were evaluated at the end of each year in relation to the initial parameters. The data analysis was performed through chi² test, Student's t test, and Mann-Whitney test. Results: we observed no significant variations in the body mass index, when comparing users and non-users during the three years of observation. Conclusion: hormone replacement therapy did not produce changes in this parameter in women properly assisted during its use.
-
Case Report10-13-2000
Primary Hyperparathyroidism after Menopause
Revista Brasileira de Ginecologia e Obstetrícia. 2000;22(4):239-241
Abstract
Case ReportPrimary Hyperparathyroidism after Menopause
Revista Brasileira de Ginecologia e Obstetrícia. 2000;22(4):239-241
DOI 10.1590/S0100-72032000000400009
Views72See moreOsteoporosis is an important disease which can affect millions of patients all over the world, leading to complications, often even to death. Prevention and the early diagnosis may help in the success of treatment but there are diseases which can occur at the same time. Primary hyperparathyroidism is a diagnosis which must be remembered in women after the menopause.
-
Original Article07-06-2005
Evaluation of body mass index of women from an outpatient gynecological general clinic
Revista Brasileira de Ginecologia e Obstetrícia. 2005;27(2):69-74
Abstract
Original ArticleEvaluation of body mass index of women from an outpatient gynecological general clinic
Revista Brasileira de Ginecologia e Obstetrícia. 2005;27(2):69-74
DOI 10.1590/S0100-72032005000200005
Views111See morePURPOSE: to determine the prevalence of overweight, obesity, and associated factors among women who visited a general gynecologic clinic in a secondary hospital of reference. METHODS: the following variables were studied: age, race, educational level, family income, job (paid work done by the women), type of the women's job, current partner, menstrual cycle characteristics at the time of interview, and body mass index (BMI). The patients were divided into three groups, according to their BMI values: <25 kg/m² (normal), between 25-29 kg/m² (overweight) and >30 kg/m² (obesity). The odds ratio (OR) and respective 95% confidence interval (95% CI) were calculated in the overweight and obese groups. Subsequently, the OR was calculated and adjusted for other variables. RESULTS: among the 676 studied women, 89.8% had received up to 8 years of formal education, 83.0% had a partner, 77.6% were Caucasian, 61.4% earned less than 5 minimum wages, and 36.0% of these women were menopausal. The prevalence of overweight was 35.6% and of obesity 24.6%. Overweight was related to age ranging from 50 to 59 years (OR: 3.22; 95% CI: 1.67-6.20) and menopause (OR: 1.52; 95% CI: 1.03-2.26), and obesity was related to menopause (OR: 2.57; 95% CI: 1.66-4.00) and to age range above 40 years (OR: 2.95; 95% CI: 1.37-6.37). According to the multiple regression analysis, only obesity was associated with age range above 40 years (OR: 2,51; 95% CI: 1.05-6.00). CONCLUSION: the prevalence rates of overweight and obesity were high in our sample of low-income women and those with less education. Obesity was associated with women aged over 40. Attempts should be made to reduce the prevalence of overweight and obesity in women.
-
Original Article07-05-2005
Predicting factors of climacteric symptoms
Revista Brasileira de Ginecologia e Obstetrícia. 2005;27(1):7-11
Abstract
Original ArticlePredicting factors of climacteric symptoms
Revista Brasileira de Ginecologia e Obstetrícia. 2005;27(1):7-11
DOI 10.1590/S0100-72032005000100004
Views75See morePURPOSE: to identify factors associated with climacteric symptoms. METHODS: a cross-sectional study of 254 women aged between 45 and 60 years was carried out at the Climacterium Outpatient Clinic of Caxias do Sul University, RS, from June to October 2002. Women with previous hysterectomy or under hormonal therapy were excluded. The climacteric symptoms were evaluated by means of the Kuppermann index and the attitudes toward menopause by a specific questionnaire. Data were analyzed by Student's t test, analysis of variance (ANOVA) and multiple linear regression analysis. RESULTS: twenty eight percent of the women reported mild climacteric symtoms, whereas 42.3% reported moderate symptoms and 30.7%, intense symptoms. The most prevalent symptoms were: irritability (87.1%), arthralgias/myalgias (77.5%) and melancholy (73.2%), while the most severe were hot flushes in 60.2% of the women, irritability and insomnia. Attitudes toward menopause, skin color and physical activity were predictors of climacteric symptoms. Positive attitudes toward menopause (p=0.01), white color (p=0.02) and the habit of practicing physical activity (0.04) were associated with less intense climacteric symptoms. Negative attitudes toward menopause were associated with worse climacteric symptoms (p<0.01). CONCLUSIONS: in the current study, the climacteric symptoms were influenced by psychosocial factors and physical activity, as well as by climacteric hypoestrogenism.
PlumX Metrics- Citations
- Citation Indexes: 5
- Usage
- Full Text Views: 41297
- Abstract Views: 1273
- Captures
- Readers: 43
-
Original Article02-16-2004
Factors associated with hot flashes in climacteric women: a population-based study
Revista Brasileira de Ginecologia e Obstetrícia. 2004;26(10):765-771
Abstract
Original ArticleFactors associated with hot flashes in climacteric women: a population-based study
Revista Brasileira de Ginecologia e Obstetrícia. 2004;26(10):765-771
DOI 10.1590/S0100-72032004001000003
Views162See morePURPOSE: to identify factors associated with the occurrence of hot flashes in climacteric women living in Campinas, São Paulo. METHODS: data bank secondary analysis of a cross-sectional descriptive population-based study. The selection of 456 women aged 45-60 years was done through area cluster sampling. Data were collected via home interviews using structured, pre-tested questionnaires provided by the International Health Foundation/International Menopause Society and by the North American Menopause Society and adapted by the authors. The analyzed variables were age, race, use of contraceptive methods and hormonal therapy, tubal ligation, body mass index, menopausal status, time since menopause, hysterectomy, and cigarette smoking. Statistical analysis was performed using the mean, median and the prevalence ratio (PR). Multiple logistic regression was performed using the stepwise selection process with a 95% confidence interval (95% CI). RESULTS: bivariate analysis showed that postmenopausal women (PR: 1.42, CI 95%: 1.06-1.90) and those who were submitted to hysterectomy (PR: 1.50, CI 95%: 1.05-2.14) had a significantly greater chance of presenting hot flashes. After applying multiple regression analysis, there was no significant association between hot flashes and any of the evaluated variables. CONCLUSION: results were consistent with previous studies. Many doubts still exist about which factors are associated with hot flashes.
PlumX Metrics- Citations
- Citation Indexes: 2
- Usage
- Full Text Views: 7791
- Abstract Views: 647
- Captures
- Readers: 1
-
Original Article01-04-2000
Variation of Blood Pressure in Users of Hormone Replacement Therapy
Revista Brasileira de Ginecologia e Obstetrícia. 2000;22(5):287-292
Abstract
Original ArticleVariation of Blood Pressure in Users of Hormone Replacement Therapy
Revista Brasileira de Ginecologia e Obstetrícia. 2000;22(5):287-292
DOI 10.1590/S0100-72032000000500006
Views131See morePurpose: to evaluate the effects of hormone replacement therapy (HRT) on the systolic and diastolic blood pressure of postmenopausal women. Methods: a total of 166 users and 136 non-users of hormone replacement were evaluated retrospectively during a period of three years. All women were assisted at the Menopause Outpatient Clinic of CAISM -- Unicamp, where the variations of these parameters were evaluated at the end of each year in relation to the initial parameters. The data analysis was performed through Student's t test, Mann-Whitney test, and the Wilcoxon nonparametric test. Results: we observed that the systolic blood pressure of HRT users was statistically lower at the end of the third year of use, compared to the initial values (p = 0.01). There was no significant difference in the diastolic blood pressure between users and non-users. Conclusion: hormone replacement therapy did not produce changes in the parameters studied in women properly assisted during the use of HRT.
-
Original Article10-14-2004
Effects of raloxifene on plasma homocysteine concentration and lipid profile in postmenopausal women
Revista Brasileira de Ginecologia e Obstetrícia. 2004;26(7):573-578
Abstract
Original ArticleEffects of raloxifene on plasma homocysteine concentration and lipid profile in postmenopausal women
Revista Brasileira de Ginecologia e Obstetrícia. 2004;26(7):573-578
DOI 10.1590/S0100-72032004000700010
Views129See morePURPOSE: to evaluate the effects of raloxifene on plasma homocysteine concentration and lipid profile in postmenopausal women. METHODS: twenty-four healthy postmenopausal women, aged 50 to 70 years, with osteopenia and/or osteoporosis, were submitted to raloxifene therapy, 60 mg/day, for six months. Plasma homocysteine concentration was determined before and after three and six months of therapy, as well as total cholesterol, HDL-cholesterol LDL-cholesterol and triglyceride levels. Plasma homocysteine was measured by a polarized immunofluorescence assay and serum lipids by the enzymatic and colorimetric method. Data were analyzed statistically by ANOVA, Newman-Keuls test and Pearson's correlation test. RESULTS: a significant decrease in total cholesterol of 15.3% (227.6±56.3 vs 200.6±29.8 vs 192.8±32.1 mg/dl; p<0.001) and LDL-cholesterol of 21.4% (151.4±46.3 vs 122.7±29.4 vs 119.0±28.6 mg/dl; p<0.001), and a significant increase in HDL-cholesterol of 9.5% (44.7±10.8 vs 52.2±12.6 vs 49.0±10.8 mg/dl; p<0.05) were observed. There was no reduction in triglyceride levels (134.9±50.3 vs 127.5±50.0 vs 121.0±36.0 mg/dl; p>0.05). Although not significant, a decrease in homocysteine by 4.5% (11.7±3.0 vs 11.0±2.9 vs 11.2±2.1 muM/l; p>0.05) was observed between the pre-and posttreatment periods, with a significant negative correlation between basal levels and posttreatment percentual reduction (r=-0.71; p<0.0001). CONCLUSIONS: raloxifene treatment, 60 mg/day, for six months caused a significant decrease in total and LDL-cholesterol and an increase in HDL-cholesterol in postmenopausal women. Plasma homocysteine concentration tended to decrease, this effect being more favorable in patients with elevated baseline levels.